Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probe

Neurobiology of Aging

Volumn 16, Issue 4, 1995, Pages 541-548

  Klunk, William E ^a   Debnath, Manik L ^a   Pettegrew, Jay W ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; Beta amyloid; Blood brain barrier; Cerebrovascular amyloid; Chrysamine G; Congo red; Diagnosis; Diazo dyes; Human brain; Neurofibrillary tangles; Synthesis

Indexed keywords

AMYLOID BETA PROTEIN; CHRYSAMINE G; CONGO RED; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BENZOATES; BIPHENYL COMPOUNDS; BRAIN; CEREBELLUM; HUMAN; MIDDLE AGE; MOLECULAR PROBES; NEUROFIBRILLARY TANGLES; PROTEIN BINDING; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029083059     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(95)00058-M     Document Type: Article

References (43)

1. Enhanced detection of Congo red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique
2. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients
3. The association between quantitative measures of dementia and senile changes in the cerebral grey matter of elderly subjects
4. Neuropathological staging of Alzheimerrelated changes
5. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
6. Neuropathologic study of 50 cases of senile dementia
7. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration
8. Tau protein and the neurofibrillary pathology of Alzheimer's disease
9. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau
10. Alzheimer's disease: The amyloid cascade hypothesis
11. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43)
12. Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases
13. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease
14. Diagnosis of Alzheimer's disease
15. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation
16. Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease
17. Quantitative evaluation of Congo red binding to amyloid-like proteins with a betapleated sheet conformation
18. Overview of dementia lacking distinctive histology: Pathologic designation of a progressive dementia
19. Dementia lacking distinctive histologic features: A common nonAlzheimer degenerative dementia
20. Cellular aspects of Alzheimer neurofibrillary pathology
21. Protein measurement with the folin phenol reagent
22. Development of a monoclonal antibody specific for β/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid and iopathy
23. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome
24. The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerations
25. Neuritic pathology and dementia in Alzheimer's disease
26. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease
27. Bilateral symmetry of morphologic lesions in Alzheimer's disease
28. Neurofibrillary tangles, dystrophic neurites (curly fibers), and abnormal phosphorylation of tau
29. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease
30. Quantitative changes in mesial temporal volume, regional cerebral bloodflow and cognition in Alzheimer's disease
31. Differences between vascular and plaque core amyloid in Alzheimer's disease
32. On the binding of Congo red by amyloid
33. Nature of mental retardation and dementia in Down Syndrome: Study with PET, CT, and neuropsychology
34. Screening for neurofibrillary tangles and argyrophilic plaques with Congo Red and polarized light
35. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype
36. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles
37. The preparation and use of radioiodinated Congo red in detecting amyloidosis
38. Labeling of cerebral amyloid in vivo with a monoclonal antibody
39. Plaques, tangles, and dementia: A quantitative study
40. Alzheimer's disease in Down's syndrome: clinicopathologic studies
41. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome
42. Amyloid angiopathy in diffuse Lewy body disease